STOCKS & COMMODITIES magazine. The Traders' Magazine

Technical Analysis of STOCKS & COMMODITIES
The Tradersí Magazine since 1982
has had over 1,226,237 subscribers from 174 different countries.
37,000 Page Tradersí Archive for $89.99

Article Archive For Keyword: Biotech

  • Betting On Biotech

    ARTICLE SYNOPSIS...What happens when you combine the promise of cutting-edge technology with the insights of 21st-century biology? How about a biotechnology sector that is primed for growth?

  • Biotech Balancing Act

    ARTICLE SYNOPSIS...Biotechnology stocks have moved up since an anticipated breakdown a month ago.

  • Biotech Breakdowns Dead Ahead

    ARTICLE SYNOPSIS...Falling below major moving averages suggests pullbacks and corrections in biotechs across the board.

  • Biotech Breakout

    ARTICLE SYNOPSIS...Weekly charts suggest that biotech stocks may have finally made their move higher.

  • Biotech Comes In

    ARTICLE SYNOPSIS...Negative divergences, engulfing candlesticks, and Fibonacci resistance conspire to send the biotechnology HOLDRS lower in mid-February.

  • Biotech ETFs: A Slice Of Medical Science

    ARTICLE SYNOPSIS...Are you interested in learning more about using exchange traded funds (ETFs) in your trading? Leslie N. Masonson, an active ETF trader, is president of Cash Management Resources, a financial consulting firm that focuses on ETF strategies. He is the autho

  • Biotech HOLDRS Break Neckline Support

    ARTICLE SYNOPSIS...A top has been brewing in the Biotech HOLDRS (BBH) for months and the stock finally broke neckline support. Now what?

  • Biotech HOLDRS Surge To Channel Resistance

    ARTICLE SYNOPSIS...The Biotech HOLDRS surged over the last two weeks, but resistance is near and Aroon is not impressed.

  • Biotech Index Breaks Consolidation

    ARTICLE SYNOPSIS...After a fairly lengthy consolidation, the Amex Biotech Index broke resistance to signal a continuation higher. But how much higher?

  • Biotech To The Future!

    ARTICLE SYNOPSIS...With gene-based medicines, tissue regeneration, and cutting-edge treatments for cancer and HIV, biotechnology promises a revolution in medicine. Are there opportunities for investors as well?

  • Biotech i-Shares At 52-Week High

    ARTICLE SYNOPSIS...Will Biotech i-Shares sustain at its new high?

  • Buy The Biotech Hype?

    ARTICLE SYNOPSIS...Inundated with calls to invest in biotech stocks? There are a few technical reasons why waiting shouldn't be the hardest part.

  • Interview: From Biotech To Quant With Scott Andrews

    ARTICLE SYNOPSIS...Scott Andrews is cofounder and CEO of InvestiQuant (, a financial services company that uses robust historical market analyses and predictive analytics. Prior to InvestiQuant, he cofounded Master The Gap and SciQuest, which he took p

  • Profiting In Biotech

    ARTICLE SYNOPSIS...Is biotech the way to go?

  • Profiting In Biotech

    ARTICLE SYNOPSIS...Is biotech investing the same as investing in slots? Is there any way to consistently build wealth in this sector? Many investors avoid biotechnology altogether, appalled at the prospect of stocks that can nosedive over 60% within minutes, while othe

  • The Biotech Bet Is Back

    ARTICLE SYNOPSIS...Does the current test of support mean that biotech stocks are finally ready to move?

  • The Biotech Index: A Long-Term Opportunity

    ARTICLE SYNOPSIS...The growth strategy provided very good returns to investors in the long term.

  • XOMA Ltd. - A Biotech Play On The Move

    ARTICLE SYNOPSIS...This biopharmaceutical development company is showing several interesting formations on its daily and weekly chart.

S&C Subscription/Renewal

Request Information From Our Sponsors 

DEPARTMENTS: Advertising | Editorial | Circulation | Contact Us | BY PHONE: (206) 938-0570

PTSK — The Professional Traders' Starter Kit
Home — S&C Magazine | Working Money Magazine | Advantage | Online Store | Traders’ Resource
Add a Product to Traders’ Resource | Message Boards | Subscribe/Renew | Free Trial Issue | Article Code | Search

Copyright © 1982–2020 Technical Analysis, Inc. All rights reserved. Read our disclaimer & privacy statement.